The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases

Journal of Allergy and Clinical Immunology

Volumn 126, Issue 4, 2010, Pages 738-744

  Katial, Rohit K ^a   Strand, Matthew ^a   Prasertsuntarasai, Theerapol ^a   Leung, Roxanne ^a   Zheng, Weihong ^a   Alam, Rafeul ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

Aspirin exacerbated respiratory disease; biomarkers; FLT3 ligand; IL 4; MMP 9

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; FLT3 LIGAND; GELATINASE B; INTERLEUKIN 4; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRYPTASE;

ADULT; AIRWAY; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CHRONIC POLYPOID SINUSITIS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DESENSITIZATION; DISEASE EXACERBATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MEGADOSE; EXPIRED AIR; FEMALE; HUMAN; INFLAMMATION; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SINUSITIS; SPUTUM ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; BIOLOGICAL MARKERS; CHRONIC DISEASE; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-4; MALE; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; MIDDLE AGED; RESPIRATORY TRACT DISEASES; SINUSITIS; SPUTUM; TREATMENT OUTCOME;

EID: 77957795704     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.06.036     Document Type: Article

References (44)

1. M. Samter, and R.F. Beers Jr. Intolerance to aspirin: clinical studies and consideration of its pathogenesis Ann Intern Med 68 1968 975 983
2. D. Stevenson, and A. Szczeklik Clinical and pathologic perspective on aspirin sensitivity and asthma J Allergy Clin Immunol 118 2006 773 786
3. D.D. Stevenson, W.W. Pleskow, R.A. Simon, D.A. Mathison, W.R. Lumry, and M. Schatz Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin J Allergy Clin Immunol 73 1984 500 507
4. J.M. Sweet, D.D. Stevenson, R.A. Simon, and D.A. Mathison Long term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma J Allergy Clin Immunol 85 1990 59 65
5. D.D. Stevenson, M.A. Hankammer, D.A. Mathison, S.C. Christensen, and R.A. Simon Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes J Allergy Clin Immunol 98 1996 751 758
6. M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson Long-term treatment with aspirin desensitization in asthmatic patients with aspirin exacerbated respiratory disease J Allergy Clin Immunol 111 2003 180 186
7. M. Berges-Gimeno, R.A. Simon, and D.D. Stevenson Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease Ann Allergy Asthma Immunol 90 2003 338 341 (Pubitemid 36363092)
8. P.E. Christie, P. Tagari, A.W. Ford-Hutchinson, S. Charlesson, P. Chee, and J.P. Arm Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects Am Rev Respir Dis 143 1991 1025 1029
9. C.M. Smith, R.J. Hawksworth, F.C. Thien, P.E. Christie, and T.H. Lee Urinaryleukotriene E4 in bronchial asthma Eur Respir J 5 1992 693 699
10. M. Sanak Kiełbasa B, Bochenek G, Szczeklik A. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients Clin Exp Allergy 34 2004 1899 1904
11. P. Daffern, D. Muilenburg, T.E. Hugli, and D.D. Stevenson Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses J Allergy Clin Immunol 104 1999 559 564
12. U.R. Juergens, S.C. Christiansen, D.D. Stevenson, and B.L. Zuraw Inhibition of monocyte leukotriene B4 production after aspirin desensitization J Allergy Clin Immunol 96 1995 148 156
13. A.R. Sousa, A. Parikh, G. Scadding, C.J. Corrigan, and T.H. Lee Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis N Engl J Med 347 2002 1524 1526
14. A. Cianferoni, J.T. Schroeder, J. Kim, J.W. Schmidt, L.M. Lichtenstein, and S.N. Georas Selective inhibition of interleukin-4 gene expression in human T cells by aspirin Blood 97 2001 1742 1749 (Pubitemid 32217242)
15. E. Macy, J.A. Bernstein, M.C. Castells, S.M. Gawchik, T.H. Lee, and R.A. Settipane Aspirin Desensitization Joint Task Force. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper Ann Allergy Asthma Immunol 98 2007 172 174
16. J.F. Piccirillo, M.G. Merritt Jr., and M.L. Richards Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20) Otolaryngol Head Neck Surg 126 2002 41 47
17. N.U. Erekosima, and R.K. Katial Assessing nasal symptom control Curr Allergy Asthma Rep 9 2009 134 139
18. R.E. Gliklich, and R. Metson Techniques for outcomes research in chronic sinusitis Laryngoscope 105 1995 387 390
19. J.V. Fahy, J. Liu, H. Wong, and H.A. Boushey Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects Am Rev Respir Dis 147 1993 1126 1131 (Pubitemid 23149867)
20. R.C. Littell, G.A. Milliken, W.W. Stroup, R.D. Wolfinger, and O. Schabenberger SAS for mixed models 2nd ed. 2006 SAS Institute Cary (NC)
21. D.D. Stevenson Aspirin desensitization in patients with AERD Clin Rev Allergy Immunol 24 2003 159 168
22. J.T. Chiu Improvement in aspirin-sensitive asthmatic subjects after rapid aspirin desensitization and aspirin maintenance (ADAM) treatment J Allergy Clin Immunol 71 1983 560 567
23. G. Rolla, A. Di Emanuele, L. Dutto, P. Marsico, F. Nebiolo, and F. Corradi Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma Allergy 59 2004 827 832
24. A. Jatakanon, S. Lim, and P.J. Barnes Changes in sputum eosinophils predict loss of asthma control Am J Respir Crit Care Med 161 2000 64 72
25. M.A. Berry, D.E. Shaw, R.H. Green, C.E. Brightling, A.J. Wardlaw, and I.D. Pavord The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma Clin Exp Allergy 35 2005 1175 1179
26. S. Nasser, P.E. Christie, R. Pfister, A.R. Sousa, A. Walls, and M. Schmitz-Schumann Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects Thorax 51 1996 64 70
27. A. Szczeklik, K. Sladek, R. Dworski, E. Nizankowska, J. Soja, and J. Sheller Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics Am J Respir Crit Care Med 154 1996 1608 1614
28. K. Sladek, R. Dworski, J. Soja, J.R. Sheller, E. Nizankowska, and J.A. Oates Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge Am J Respir Crit Care Med 149 1994 940 946
29. J.V. Bosso, L.B. Schwartz, and D.D. Stevenson Tryptase and histamine release during aspirin-induced respiratory reactions Am J Respir Crit Care Med 88 1991 830 837
30. K. Sladek, and A. Szczeklik Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma Eur Respir J 6 1993 391 399
31. G. Bochenek, K. Nagraba, E. Nizankowska, and A. Szczeklik A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge J Allergy Clin Immunol 111 2003 743 749
32. S.B. Early, E. Barekzi, J. Negri, K. Hise, L. Borish, and J.W. Steinke Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells Am J Respir Cell Mol Biol 36 2007 715 720
33. J.W. Steinke, J. Culp, E. Kropf, and L. Borish Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: possible role in therapeutic benefit associated with aspirin desensitization J Allergy Clin Immunol 124 2009 724 730
34. Z. Shao, T.O. Makinde, H.S. McGee, X. Wang, and D.K. Agrawal Fms-like tyrosine kinase 3 ligand regulates migratory pattern and antigen uptake of lung dendritic cell subsets in a murine model of allergic airway inflammation J Immunol 183 2009 7531 7538
35. Y. He, A.A. Pimenov, J.V. Nayak, J. Plowey, L.D. Falo Jr., and L. Huang Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo Hum Gene Ther 11 2000 547 554
36. J.H. Edwan, G. Perry, J.E. Talmadge, and D.K. Agrawal Flt-3 ligand reverses late allergic response and airway hyper-responsiveness in a mouse model of allergic inflammation J Immunol 172 2004 5016 5023
37. J.H. Edwan, J.E. Talmadge, and D.K. Agrawal Treatment with Flt3 ligand plasmid reverses allergic airway inflammation in ovalbumin-sensitized and -challenged mice Int Immunopharmacol 5 2005 345 357
38. M.M. Gueders, J.M. Foidart, A. Noel, and D.D. Cataldo Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases Eur J Pharmacol 533 2006 133 144
39. M. Cundall, Y. Sun, C. Miranda, J.B. Trudeau, S. Barnes, and S.E. Wenzel Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids J Allergy Clin Immunol 112 2003 1064 1071
40. D.D. Cataldo, K.G. Tournoy, K. Vermaelen, C. Munaut, J.M. Foidart, and R. Louis Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation Am J Pathol 161 2002 491 498
41. I. Ohno, H. Ohtani, Y. Nitta, J. Suzuki, H. Hoshi, and M. Honma Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation Am J Respir Cell Mol Biol 16 1997 212 219
42. E.A. Kelly, W.W. Busse, and N.N. Jarjour Increased matrix metalloproteinase-9 in the airway after allergen challenge Am J Respir Crit Care Med 162 2000 1157 1161
43. D.D. Cataldo, J. Bettiol, A. Noël, P. Bartsch, J.M. Foidart, and R. Louis Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge Chest 122 2002 1553 1559
44. H. Vliagoftis, A. Schwingshackl, C.D. Milne, M. Duszyk, M.D. Hollenberg, and J.L. Wallace Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells J Allergy Clin Immunol 106 2000 537 545